You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • AB0318 Abatacept (abt) equivalent to anti-tumor necrosis factor a (tnfa) in terms of joint destruction inhibition: multicenter study of 107 patients treated for 52 weeks

Citation Tools

Article menu
Download PDFPDF
Abstracts accepted for publication
Rheumatoid arthritis - other biologic treatment
AB0318 Abatacept (abt) equivalent to anti-tumor necrosis factor a (tnfa) in terms of joint destruction inhibition: multicenter study of 107 patients treated for 52 weeks

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ayabe K, Takeuchi K, Matsushita M, et al
AB0318 Abatacept (abt) equivalent to anti-tumor necrosis factor a (tnfa) in terms of joint destruction inhibition: multicenter study of 107 patients treated for 52 weeks
Annals of the Rheumatic Diseases 2013;72:A884.